Previous 10 | Next 10 |
MoneyShow.com news releases related Moneyshow.com news releases and Moneyshow.com press releases from 01/03/23 04:00:00 on US and Canada Markets.
Geopolitical division — given Russia’s invasion of Ukraine and rising tensions in the South China sea — continue to fuel demand/supply imbalances; as such, price volatility and shocks to global commerce could remain in 2023, cautions Omar Ayales, editor of Gold Charts R Us. ...
Sociedad Quimica Y Minera De Chile S.A. (SQM) produces and distributes specialty plant nutrients, iodine and its derivatives, lithium and its derivatives, potassium chloride and sulfate, industrial chemicals, and other products and services, explains notes Louis Navellier, editor of Navellier Gro...
As I write about my favorite pick for 2023, I am still quite bearish on the short term outlook; I expect stocks to find a bottom between 2,800 to 3,200 in the first half of 2023, suggests Steve Reitmeister, editor of StockNews. For further details see: Top Picks 2023- Direxion Small Cap Bul...
Just for fun, I recently searched for stocks that had fallen 10% or more from their 52-week highs, thinking that some of them may have declined due to market factors that didn’t reflect the company’s potential, asserts Nancy Zambell, editor of Cabot Stock of the Month. For further...
AutoZone (AZO) — a Top Pick for 2023 — is a leading retailer and distributor of automotive replacement parts and accessories. It has 6,943 stores and offers national brand and private-label products, notes Taylor Conrad, an analyst with Argus Research. For further details see: ...
Nokia (NOK) is one of the world’s primary providers of telecom equipment and is a Top Pick for conservative investors in the coming year, explains Bruce Kaser, editor of Cabot Turnaround Letter. For further details see: Top Picks 2023- Nokia Corporation NOK
It’s no secret that we humans can be a vain bunch. We want to turn back the hands of time as we age. That’s why elective cosmetic surgery has surged past pre-pandemic levels, notes Jimmy Mengel, editor of The Profit Sector. For further details see: Top Picks 2023- InMode INMD
Bet on one thing: 2023 will be the year of the bargain hunters. With inflation still at uncomfortably high levels, shoppers will seek to stretch their dollars as far as possible, explains Gordon Pape, editor of Internet Wealth Builder. For further details see: Top Picks 2023- The TJX Compan...
Catalyst Pharmaceuticals (CPRX) is a small-cap biopharma company focused on in-licensing, developing and commercializing novel medicines to treat rare diseases. It has a market cap of just under $2 billion, notes Tyler Laundon, editor of Cabot-Small Cap Confidential. For further details see: ...
Consensus forecasts call for very low or slightly negative U.S. economic growth in the first half of 2023, with some improvement in the second half of the year, observes Rich Moroney, editor of Dow Theory Forecasts. For further details see: Top Picks 2023- Vertex Pharmaceuticals VRTX
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
1.41%Change Percent:
Palisade Bio Inc. Company Name:
PALI Stock Symbol:
NASDAQ Market: